NCT04026581

Brief Summary

The goal of this project is to test a new AAC-BCI device comparing gel and dry electrode headgear used for communication while providing clinical care. Innovative resources will be employed to support the standard of care without considering limitations based on service billing codes. Clinical services will include AAC assessment, AAC-BCI device and treatment to individuals with minimal movement due to amyotrophic lateral sclerosis (ALS), brain stem strokes, severe cerebral palsy, traumatic brain injury (TBI) and their family support person. This is a descriptive study designed to measure and monitor the communication performance of individuals using the AAC-BCI, any other AAC strategies, their user satisfaction and perceptions of communication effectiveness, and the satisfaction of the family support persons.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2019

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 5, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 17, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 19, 2019

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

December 6, 2023

Status Verified

December 1, 2023

Enrollment Period

4.3 years

First QC Date

July 17, 2019

Last Update Submit

December 5, 2023

Conditions

Outcome Measures

Primary Outcomes (24)

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    Baseline vs. 1 month

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    1 month vs. 2 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    2 months vs. 3 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    3 months vs. 4 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    4 months vs. 5 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    5 months vs. 6 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    6 months vs. 7 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    7 months vs. 8 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    8 months vs. 9 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    9 months vs. 10 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    10 months vs. 11 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    11 months vs. 12 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    12 months vs. 13 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    13 months vs. 14 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    14 months vs. 15 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    15 months vs. 16 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    16 months vs. 17 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    17 months vs. 18 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    18 months vs. 19 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    19 months vs. 20 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    20 months vs. 21 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    21 months vs. 22 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    22 months vs. 23 months

  • Change in daily communication performance

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

    23 months vs. 24 months

Secondary Outcomes (24)

  • User satisfaction of speech generating device (SGD) for daily communication

    Baseline vs. 1 month

  • User satisfaction of speech generating device (SGD) for daily communication

    1 month vs. 2 months

  • User satisfaction of speech generating device (SGD) for daily communication

    2 months vs. 3 months

  • User satisfaction of speech generating device (SGD) for daily communication

    3 months vs. 4 months

  • User satisfaction of speech generating device (SGD) for daily communication

    4 months vs. 5 months

  • +19 more secondary outcomes

Study Arms (2)

Assessment

A comprehensive AAC assessment collecting clinical and personal data required to select a speech-generating device (SGD) is conducted along with a trial of three AAC technology solutions, followed by a trial for BCI access to an AAC system.

Behavioral: Speech generating device (SGD) evaluation including BCI access

Training and Treatment

AAC training and treatment services will be provided and communication performance outcomes monitored over the course of studying clinical treatment services. At monthly home visits the SLP gathers clinical and personal data on communication performance outcomes and user satisfaction of their AAC system and any alternative access methods.

Behavioral: Training and treatment

Interventions

At the initial evaluation the participants will review the full range of AAC options and speech generating devices (SGDs) and complete a speech and language evaluation. The second evaluation date will involve a trial of SGDs matched to the participant's assessment results. The third visit is the trial of an AAC system with BCI access. Should the dry electrode headgear for BCI access prove ineffective, then the gel electrode cap will be offered to the participant for trial. At the end of the third visit, the evaluation results will be discussed with participant and family, and they will be asked to select the preferred SGD.

Assessment

Participants receive training on the selected SGD followed by monthly treatment sessions from the SLP who monitors performance. In some cases the participants' SGD will be an AAC system with BCI access. In this case training will also include an identified system support person. Use of the SGD is monitored on a monthly basis through home visits and/or tele-practice sessions, when requested. Technical support for the SGD is provided on an as needed basis or when requested by the participant or support person.

Training and Treatment

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals with severe communication disabilities and minimal movement impairment.

You may qualify if:

  • natural speech does not meet daily communication needs requiring using a speech generating device
  • Has a diagnosis resulting in minimal movement interfering with direct selection to a keyboard or AAC display
  • age 14 and above
  • able to read a standard computer screen
  • able to follow instructions
  • English as their native language

You may not qualify if:

  • history of photosensitive epilepsy
  • open sores on the scalp
  • history of uncorrectable hearing loss
  • unavailable to participate during the times scheduled for the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

AAC Institute Clinic (ICAN Talk Clinic)

Carnegie, Pennsylvania, 15102, United States

Location

University of Pittsburgh, AAC Performance and Testing Laboratory

Pittsburgh, Pennsylvania, 15260, United States

Location

MeSH Terms

Conditions

Amyotrophic Lateral SclerosisBrain Stem InfarctionsCerebral PalsyBrain Injuries, TraumaticSpeech Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesTDP-43 ProteinopathiesNeuromuscular DiseasesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic DiseasesBrain InfarctionBrain IschemiaCerebrovascular DisordersBrain DiseasesStrokeVascular DiseasesCardiovascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisBrain Damage, ChronicBrain InjuriesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Katya Hill, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 17, 2019

First Posted

July 19, 2019

Study Start

June 5, 2019

Primary Completion

September 30, 2023

Study Completion

September 30, 2023

Last Updated

December 6, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices)

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 9 months and ending 36 months following article publication.
Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee.

Locations